Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0T8ZL
|
|||
| Former ID |
DNC006528
|
|||
| Drug Name |
3-(2-carboxy-3-mercaptopropyl)benzoic acid
|
|||
| Synonyms |
Thiol-Based Inhibitor, 7a; CHEMBL206699; CTK8A8777; BDBM17764; AKOS015965664; 3-[2-carboxy-2-(sulfanylmethyl)ethyl]benzoic acid; 3-(2-CARBOXY-3-MERCAPTO-PROPYL)-BENZOIC ACID
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C11H12O4S
|
|||
| Canonical SMILES |
C1=CC(=CC(=C1)C(=O)O)CC(CS)C(=O)O
|
|||
| InChI |
1S/C11H12O4S/c12-10(13)8-3-1-2-7(4-8)5-9(6-16)11(14)15/h1-4,9,16H,5-6H2,(H,12,13)(H,14,15)
|
|||
| InChIKey |
LQVBVNPZOILYPX-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Glutamate carboxypeptidase II (GCPII) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Alanine, aspartate and glutamate metabolism | |||
| Metabolic pathways | ||||
| Vitamin digestion and absorption | ||||
| NetPath Pathway | TCR Signaling Pathway | |||
| TNFalpha Signaling Pathway | ||||
| Reactome | Amino acid synthesis and interconversion (transamination) | |||
| WikiPathways | One Carbon Metabolism | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Structural optimization of thiol-based inhibitors of glutamate carboxypeptidase II by modification of the P1' side chain. J Med Chem. 2006 May 18;49(10):2876-85. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.